About:
Fresh Wind Biotechnologies is developing cellular immunotherapies to improve the outcome of cancer patients. To help pioneer discoveries in treating cancer, Fresh Wind is focused on integrating high-throughput platforms, state-of-art data science and engineering and innovative cellular therapies to advance precision oncology. This includes developing a next generation process for tumor-infiltrating lymphocytes manufacturing to cut down both cost and time for clients. Fresh Wind recently expanded their tumor organoid services and single cell sequence data analysis of final tumor organoids to enhance oncology drug development projects.